Importantly, this de novo CCR7 expression may represent a major mechanism by which alloreactive (i.e., activated) NK cells can migrate to lymph nodes, kill recipient's DCs, and prevent priming of alloreactive donor's T cells as well as induction of graft-versus-host disease (GvHD) [36, 38]. Here, CCR7 is linked to graft versus host disease.